Novel Lactams as SARM1 Inhibitors for Treating Axonal Degeneration
- PMID: 40529072
- PMCID: PMC12169446
- DOI: 10.1021/acsmedchemlett.5c00241
Novel Lactams as SARM1 Inhibitors for Treating Axonal Degeneration
Abstract
Provided herein are novel lactams as SARM1 inhibitors, pharmaceutical compositions, use of such compounds in treating axonal degeneration and processes for preparing such compounds.
Published 2025 by American Chemical Society.
Similar articles
-
Novel Substituted Lactams as 5‑HT1A Agonists for Treating Neuropsychiatric Diseases.ACS Med Chem Lett. 2025 May 16;16(6):950-951. doi: 10.1021/acsmedchemlett.5c00270. eCollection 2025 Jun 12. ACS Med Chem Lett. 2025. PMID: 40529073
-
SARM1: The Checkpoint of Axonal Degeneration in the Nervous System Disorders.Mol Neurobiol. 2025 Jul;62(7):9240-9257. doi: 10.1007/s12035-025-04835-3. Epub 2025 Mar 17. Mol Neurobiol. 2025. PMID: 40097763 Review.
-
Novel Compounds as CDK2 Inhibitors for Treating Cancer.ACS Med Chem Lett. 2024 Dec 10;16(1):14-15. doi: 10.1021/acsmedchemlett.4c00574. eCollection 2025 Jan 9. ACS Med Chem Lett. 2024. PMID: 39811118
-
Pyrrolopyrazine Compounds as ERK5 Inhibitors for Treating Cancer.ACS Med Chem Lett. 2024 Dec 11;16(1):16-17. doi: 10.1021/acsmedchemlett.4c00580. eCollection 2025 Jan 9. ACS Med Chem Lett. 2024. PMID: 39811115
-
SARM1 in the pathogenesis of immune-related disease.Toxicol Res (Camb). 2024 Dec 8;13(6):tfae208. doi: 10.1093/toxres/tfae208. eCollection 2024 Dec. Toxicol Res (Camb). 2024. PMID: 39664502 Review.
References
-
- Wang, J. ; Shi, Y. ; Tian, J. ; Tang, L. ; Cao, F. . Investigating the role of SARM1 in central nervous system. Ibrain 2024, in press. 10.1002/ibra.12173. - DOI
-
- Doerksen, A. H. ; Herath, N. N. ; Sanders, S. S. . Fat traffic control: S-acylation in axonal transport. Mol. Pharmacol. 2025, in press. 10.1016/j.molpha.2025.100039. https://www.sciencedirect.com/science/article/pii/S0026895X25152991. - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources